Tag: Regulations

1367: Antony Davies – Laws That Harm the Disabled

F1367: Antony Davies – Laws That Harm the Disabled
In 1990, the U.S. government enacted the Americans with Disabilities Act. This law attempted to protect the disabled in the labor market by prohibiting discriminatory behavior on the basis of disability. A law specifically designed to ensure that the disabled got a fair shake in the labor market instead resulted in decreased employment rates for the disabled.

In 1990, the U.S. government enacted the Americans with Disabilities Act. This law attempted to protect the disabled in the labor market by prohibiting discriminatory behavior on the basis of disability. A law specifically designed to ensure that the disabled got a fair shake in the labor market instead resulted in decreased employment rates for the disabled.

Why? There are a couple of reasons. First, the law made it expensive for businesses to hire the disabled. Regulators have deemed, among other things, that employers will need to modify an employee’s physical environment, offer the employee additional training, give him extra time to complete tasks, and even hire interpreters. All these things increase the cost of doing business.

Second, the law made it difficult to terminate disabled workers, even when warranted. But how is a business to prove that it terminated a disabled worker because of something other than the worker’s disability? The answer that many businesses seem to have arrived at, although few will admit it, is not to hire the disabled in the first place.

It turns out to be easier for an employer to prove that it did not hire a disabled worker for a reason unrelated to the worker’s disability than to prove that it fired the worker for such a reason. Consequently, the Americans with Disabilities Act actually led to a decrease in employment rates for the disabled.

—Antony Davies, James R. Harrigan

1366: Antony Davies – Seat Belt Laws

W1366: Antony Davies - Seat Belt Laws
Forty-nine states now mandate seat belt use and motor vehicle fatalities have decreased. But there is more to the story. As more drivers used seat belts, fatalities for pedestrians and cyclists increased. Why? As seat belt use rose, driving became safer. As driving became safer, the cost to drivers of being inattentive fell. And as the cost of being inattentive fell, drivers could afford to exercise less care. So as safety regulations make drivers safer, pedestrians and cyclists face greater risk. —Antony Davies, James R. Harrigan
Forty-nine states now mandate seat belt use and motor vehicle fatalities have decreased. But there is more to the story. As more drivers used seat belts, fatalities for pedestrians and cyclists increased. Why? As seat belt use rose, driving became safer. As driving became safer, the cost to drivers of being inattentive fell. And as the cost of being inattentive fell, drivers could afford to exercise less care. So as safety regulations make drivers safer, pedestrians and cyclists face greater risk. —Antony Davies, James R. HarriganDownload Print Quality (7680×4020) 220KB  |  Normal Quality (3840×2010) 119KB
Forty-nine states now mandate seat belt use and motor vehicle fatalities have decreased. But there is more to the story. As more drivers used seat belts, fatalities for pedestrians and cyclists increased. Why? As seat belt use rose, driving became safer. As driving became safer, the cost to drivers of being inattentive fell. And as the cost of being inattentive fell, drivers could afford to exercise less care. So as safety regulations make drivers safer, pedestrians and cyclists face greater risk. —Antony Davies, James R. HarriganDownload Print Quality (7680×7680) 343KB  |  Normal Quality (3840×3840) 173KB

Forty-nine states now mandate seat belt use and motor vehicle fatalities have decreased. But there is more to the story. As more drivers used seat belts, fatalities for pedestrians and cyclists increased. Why? As seat belt use rose, driving became safer. As driving became safer, the cost to drivers of being inattentive fell. And as the cost of being inattentive fell, drivers could afford to exercise less care. So as safety regulations make drivers safer, pedestrians and cyclists face greater risk. —Antony Davies, James R. Harrigan

1362: Mary Ruwart – Patients Die Waiting for New Drugs

W1362: Mary Ruwart - Patients Die Waiting for New Drugs
Cancer patients often die waiting for new drugs to be approved by the FDA? Abigail Burroughs had squamous cell carcinoma, diagnosed when she was only 19 years old. She tried unsuccessfully to get FDA permission to try a new drug (Erbitux) that had shown success against her type of cancer. The FDA refused, and Abigail died at age 21. Abigail’s father formed the Abigail Alliance and sued the FDA. However, the courts ruled that Americans do not have the constitutional right to save their lives with drugs not approved by the FDA. —Mary Ruwart
Cancer patients often die waiting for new drugs to be approved by the FDA? Abigail Burroughs had squamous cell carcinoma, diagnosed when she was only 19 years old. She tried unsuccessfully to get FDA permission to try a new drug (Erbitux) that had shown success against her type of cancer. The FDA refused, and Abigail died at age 21. Abigail’s father formed the Abigail Alliance and sued the FDA. However, the courts ruled that Americans do not have the constitutional right to save their lives with drugs not approved by the FDA. —Mary RuwartDownload Print Quality (7680×4020) 235KB  |  Normal Quality (3840×2010) 127KB
Cancer patients often die waiting for new drugs to be approved by the FDA? Abigail Burroughs had squamous cell carcinoma, diagnosed when she was only 19 years old. She tried unsuccessfully to get FDA permission to try a new drug (Erbitux) that had shown success against her type of cancer. The FDA refused, and Abigail died at age 21. Abigail’s father formed the Abigail Alliance and sued the FDA. However, the courts ruled that Americans do not have the constitutional right to save their lives with drugs not approved by the FDA. —Mary RuwartDownload Print Quality (7680×7680) 362KB  |  Normal Quality (3840×3840) 177KB

Cancer patients often die waiting for new drugs to be approved by the FDA? Abigail Burroughs had squamous cell carcinoma, diagnosed when she was only 19 years old. She tried unsuccessfully to get FDA permission to try a new drug (Erbitux) that had shown success against her type of cancer. The FDA refused, and Abigail died at age 21. Abigail’s father formed the Abigail Alliance and sued the FDA. However, the courts ruled that Americans do not have the constitutional right to save their lives with drugs not approved by the FDA. —Mary Ruwart

1357: Mary Ruwart – Zimbabwe’s Elephants

W1357: Mary Ruwart - Zimbabwe's Elephants
In Kenya, the elephant population dropped from 65,000 to 19,000 even though elephant hunting was forbidden. In Zimbabwe, however, natives can claim, or homestead, elephants living on their lands. Natives can legally sell permits to hunt them. Zimbabwe’s elephant population grew from 30,000 to 43,000. People will protect the environment when they own it and profit from it. —Mary J Ruwart
In Kenya, the elephant population dropped from 65,000 to 19,000 even though elephant hunting was forbidden. In Zimbabwe, however, natives can claim, or homestead, elephants living on their lands. Natives can legally sell permits to hunt them. Zimbabwe’s elephant population grew from 30,000 to 43,000. People will protect the environment when they own it and profit from it. —Mary J RuwartDownload Print Quality (7680×4020) 218KB  |  Normal Quality (3840×2010) 111KB
In Kenya, the elephant population dropped from 65,000 to 19,000 even though elephant hunting was forbidden. In Zimbabwe, however, natives can claim, or homestead, elephants living on their lands. Natives can legally sell permits to hunt them. Zimbabwe’s elephant population grew from 30,000 to 43,000. People will protect the environment when they own it and profit from it. —Mary J RuwartDownload Print Quality (7680×7680) 304KB  |  Normal Quality (3840×3840) 147KB

In Kenya, the elephant population dropped from 65,000 to 19,000 even though elephant hunting was forbidden. In Zimbabwe, however, natives can claim, or homestead, elephants living on their lands. Natives can legally sell permits to hunt them. Zimbabwe’s elephant population grew from 30,000 to 43,000. People will protect the environment when they own it and profit from it. —Mary J Ruwart

1354: Mary Ruwart – Heart Disease and Aspirin

W1354: Mary Ruwart - Heart Disease and Aspirin
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our WorldDownload Print Quality (7680×4020) 170KB  |  Normal Quality (3840×2010) 84KB
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our WorldDownload Print Quality (7680×7680) 261KB  |  Normal Quality (3840×3840) 124KB

The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World

1353: Mary Ruwart – Expensive Medicine

W1353: Mary Ruwart - Expensive Medicine
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our WorldDownload Print Quality (7680×4020) 226KB  |  Normal Quality (3840×2010) 116KB
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our WorldDownload Print Quality (7680×7680) 354KB  |  Normal Quality (3840×3840) 172KB

We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World

1352: Mary Ruwart – A Parent’s Choice vs the FDA

F1352: Mary Ruwart - A Parent's Choice vs the FDA
When four-year-old Thomas Navarro developed a deadly brain tumor, his parents were appalled at the frequent side effects of the radiation treatments. When they expressed their desire to try a gentler experimental treatment, doctors threatened to take Thomas from his parents and put him in state custody.
When four-year-old Thomas Navarro developed a deadly brain tumor, his parents were appalled at the frequent side effects of the radiation treatments. When they expressed their desire to try a gentler experimental treatment, doctors threatened to take Thomas from his parents and put him in state custody.

The chemotherapy almost killed Thomas. The Navarros refused further treatments, only to find that the FDA wouldn’t permit Thomas to receive the gentler experimental treatment unless he had radiation too. In frustration, the Navarros went to Congress, as other patients have done, to plead for permission to use new drugs not yet approved by the FDA. After a year and a half of fighting, when Thomas was expected to live for only two more weeks, the FDA finally permitted him to have a “compassionate use” exemption.

By that time, Thomas had developed new tumors, called leptomeningial-sarcoma, from his initial chemotherapy. Nevertheless, the experimental treatment kept Thomas going for several more months. How much longer might Thomas have lived if we had honored his parents’ choice in the earlier stages of his disease?

—Dr. Mary J. Ruwart, Healing Our World

1335: James Madison – Charity is No Part of Government

W1335: James Madison – Charity is No Part of Government
Charity is no part of the legislative duty of the government. —James Madison

Charity is no part of the legislative duty of the government. —James Madison

1334: John Stossel – The Free Market is Magical

W1334: John Stossel – The Free Market is Magical
I viewed the marketplace as a cruel place, where you need intervention by government to protect people. But after watching the regulators work, I have come to believe that markets are magical, and the best protectors of the consumer. It is my job to explain the beauties of the free market. —John Stossel
I viewed the marketplace as a cruel place, where you need intervention by government to protect people. But after watching the regulators work, I have come to believe that markets are magical, and the best protectors of the consumer. It is my job to explain the beauties of the free market. —John StosselDownload Print Quality (3840×2010) 5.45MB  |  Normal Quality (1920×1005) 263KB
I viewed the marketplace as a cruel place, where you need intervention by government to protect people. But after watching the regulators work, I have come to believe that markets are magical, and the best protectors of the consumer. It is my job to explain the beauties of the free market. —John StosselDownload Print Quality (3840×2744) 7.49MB  |  Normal Quality (1920×1372) 343KB

I viewed the marketplace as a cruel place, where you need intervention by government to protect people. But after watching the regulators work, I have come to believe that markets are magical, and the best protectors of the consumer. It is my job to explain the beauties of the free market. —John Stossel

1287: Henry Hazlitt – Needles Bureaucrats

W1287: Henry Hazlitt - Needles Bureaucrats
When your money is taken by a thief, you get nothing in return. When your money is taken through taxes to support needless bureaucrats, precisely the same situation exists. —Henry Hazlitt
When your money is taken by a thief, you get nothing in return. When your money is taken through taxes to support needless bureaucrats, precisely the same situation exists. —Henry HazlittDownload Print Quality (3840×2010) 2.42MB  |  Normal Quality (1920×1005) 242KB
When your money is taken by a thief, you get nothing in return. When your money is taken through taxes to support needless bureaucrats, precisely the same situation exists. —Henry HazlittDownload Print Quality (3840×2744) 3.16MB  |  Normal Quality (1920×1372) 302KB

When your money is taken by a thief, you get nothing in return. When your money is taken through taxes to support needless bureaucrats, precisely the same situation exists. —Henry Hazlitt